9 December 2024
Blenrep (belantamab mafodotin) combination accepted for priority review in China in relapsed/refractory multiple myeloma GSK plc (LSE/NYSE: GSK) today announced that the National Medical Products…
US FDA accepts GSK’s submission for the use of Nucala (mepolizumab) in COPD GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA)…
6 December 2024
AVI Global Trust – Annual overview from QuotedData 6th December 2024 Building on solid foundations AVI Global (AGT) continues to demonstrate the value of a clear strategy…
5 December 2024
Hargreaves Services plc (“Hargreaves”, the “Company” or the “Group”) Trading Update and Notice of Interim Results Hargreaves Services plc (AIM: HSP), a diversified group delivering services…
Sequoia Economic Infrastructure Income Fund Limited (the “Company”) STRONG INTEREST INCOME GENERATION FROM RESILIENT PORTFOLIO WELL POSITIONED TO DELIVER ATTRACTIVE AND SUSTAINABLE RETURNS Interim…
GSK and Zhifei revise and extend strategic vaccine collaboration in China GSK plc (LSE/NYSE: GSK) today announced that it has entered into an agreement…
Imfinzi approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer Based on ADRIATIC Phase III trial…
4 December 2024
Finsbury Growth & Income Trust PLC (the “Company”) This announcement contains regulated information Annual Financial Report for the year ended 30 September 2024 Finsbury…